SLC5A2 and hydrops fetalis: In an assessment including two large clinical RCTs, EMPEROR-REDUCE and DAPA-HF, Zannad et al. noted that SGLT2 inhibitors can prevent the recurrence of HHF in patients with HF with reduced ejection fraction (EF) (11).